The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia-Reference-Cited by-同舟云学术

The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia

Published:2022-07-15 Issue:1 Volume:25 Page:919-929
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Danchenko Natalya¹,Johnston Karissa M.²,Whalen John³

Affiliation:

1. Ipsen, Boulogne-Billancourt, France

2. Broadstreet Health Economics and Outcomes Research, Vancouver, Canada

3. Ipsen Slough, London, UK

Funder

Ipsen

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2092354

Reference59 articles.

1. Spasticity in children and young people with non-progressive brain disorders: summary of NICE guidance

2. Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement

3. Botulinum toxin assessment, intervention and aftercare for paediatric and adult niche indications including pain: international consensus statement

4. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement

5. Mayo Clinic. Cervical dystonia. 2021. [cited 2021 Jun 22]. https://www.mayoclinic.org/diseases-conditions/cervical-dystonia/symptoms-causes/syc-20354123?lang=en.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Botulinum toxin in the rehabilitation of painful syndromes: multiperspective literature analysis, lexical analysis and systematic review of randomized controlled trials;European Journal of Translational Myology;2024-05-20

2. Cost-effectiveness of abobotulinumtoxinA plus best supportive care compared with best supportive care alone for early treatment of adult lower limb spasticity following an acute event;PLOS ONE;2024-02-01

3. A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece;Toxins;2023-09-08

4. A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity;Toxins;2023-08-30